This hypothesis has a potential to make a positive impact in cancer research and drug discovery. For cancer patients, it might help to accelerate both the development of promising therapies and the potential of personalized medicine — treatments based on an individual’s unique immune deficiency. This is a very interesting and unique idea which needs more research.